Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate

By Gonzalo Ximena   Drobniewski Francis  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 366-369

Oxford University Press

Access to resources Recommend Favorite

The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for “New Use”

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 206-212

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Drug Resistant Pulmonary Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 53-57

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 110-117

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Treatment of Drug-Resistant Tuberculosis: State of the Art

By  

Current Respiratory Medicine Reviews, Vol. 13, Iss. 2, 2017-12 ,pp. : 73-81

Bentham Science Publishers

Access to resources Recommend Favorite